| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2635 | 2021 |
| Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis J Stone, H Fraser, AG Lim, JG Walker, Z Ward, L MacGregor, A Trickey, ... The Lancet Infectious Diseases 18 (12), 1397-1409, 2018 | 208 | 2018 |
| The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ... Journal of hepatology 76 (4), 771-780, 2022 | 155 | 2022 |
| Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia V Mirtskhulava, R Kempker, KL Shields, MK Leonard, T Tsertsvadze, ... The International Journal of Tuberculosis and Lung Disease 12 (5), 513-519, 2008 | 138 | 2008 |
| Launch of a nationwide hepatitis C elimination program—Georgia, April 2015 K Mitruka, T Tsertsvadze, M Butsashvili, A Gamkrelidze, P Sabelashvili, ... MMWR Morb Mortal Wkly Rep 64 (28), 753-7, 2015 | 109 | 2015 |
| Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia E Shapatava, KE Nelson, T Tsertsvadze, C Del Rio Drug and alcohol dependence 82, S35-S38, 2006 | 104 | 2006 |
| Etiology of neonatal blood stream infections in Tbilisi, Republic of Georgia N Macharashvili, E Kourbatova, M Butsashvili, T Tsertsvadze, LA McNutt, ... International Journal of Infectious Diseases 13 (4), 499-505, 2009 | 103 | 2009 |
| Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national … E Dolmazashvili, A Abutidze, N Chkhartishvili, M Karchava, L Sharvadze, ... European journal of gastroenterology & hepatology 29 (11), 1223-1230, 2017 | 95 | 2017 |
| Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors M Butsashvili, T Tsertsvadze, LA McNutt, G Kamkamidze, R Gvetadze, ... European journal of epidemiology 17, 693-695, 2001 | 94 | 2001 |
| National progress toward hepatitis C elimination—Georgia, 2015–2016 L Gvinjilia MMWR. Morbidity and mortality weekly report 65, 2016 | 88 | 2016 |
| Assessment of quality of life in people living with HIV in Georgia E Karkashadze, MA Gates, N Chkhartishvili, J DeHovitz, T Tsertsvadze International journal of STD & AIDS 28 (7), 672-678, 2017 | 74 | 2017 |
| Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia K Stvilia, T Tsertsvadze, L Sharvadze, M Aladashvili, C Del Rio, ... Journal of Urban Health 83, 289-298, 2006 | 62 | 2006 |
| The role of screening and treatment in national progress toward hepatitis C elimination—Georgia, 2015–2016 M Nasrullah MMWR. Morbidity and mortality weekly report 66, 2017 | 60 | 2017 |
| Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia F Averhoff, S Shadaker, A Gamkrelidze, T Kuchuloria, L Gvinjilia, V Getia, ... Journal of hepatology 72 (4), 680-687, 2020 | 52 | 2020 |
| Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients MH Kuniholm, J Mark, M Aladashvili, N Shubladze, G Khechinashvili, ... International Journal of Infectious Diseases 12 (1), 51-56, 2008 | 52 | 2008 |
| High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment M Karchava, J Waldenström, M Parker, R Hallack, L Sharvadze, ... Hepatology Research 45 (13), 1292-1298, 2015 | 43 | 2015 |
| Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia N Chkhartishvili, RR Kempker, N Dvali, L Abashidze, L Sharavdze, ... BMC infectious diseases 13, 1-7, 2013 | 43 | 2013 |
| HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia M Zarandia, T Tsertsvadze, JK Carr, Y Nadai, JL Sanchez, K Nelson AIDS Research & Human Retroviruses 22 (5), 470-476, 2006 | 42 | 2006 |
| Three years of progress toward achieving hepatitis C elimination in the country of Georgia, April 2015–March 2018 T Tsertsvadze, A Gamkrelidze, N Chkhartishvili, A Abutidze, L Sharvadze, ... Clinical Infectious Diseases 71 (5), 1263-1268, 2020 | 41 | 2020 |
| Risk factors for hepatitis C virus infection among blood donors in Georgia N Zaller, KE Nelson, M Aladashvili, N Badridze, C Del Rio, T Tsertsvadze European journal of epidemiology 19, 547-553, 2004 | 41 | 2004 |
